Key Insights

Highlights

Success Rate

86% trial completion

Published Results

41 trials with published results (18%)

Research Maturity

102 completed trials (45% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 39/100

Termination Rate

7.5%

17 terminated out of 227 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

13%

29 trials in Phase 3/4

Results Transparency

40%

41 of 102 completed with results

Key Signals

41 with results86% success17 terminated

Data Visualizations

Phase Distribution

174Total
Not Applicable (23)
Early P 1 (4)
P 1 (59)
P 2 (59)
P 3 (21)
P 4 (8)

Trial Status

Completed102
Unknown44
Recruiting34
Terminated17
Active Not Recruiting12
Withdrawn10

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 102 completed trials

Clinical Trials (227)

Showing 20 of 20 trials
NCT07574541Phase 2Not Yet Recruiting

Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance

NCT00027326Enrolling By InvitationPrimary

Collection of Blood and Urine From Patients Undergoing Radiation Therapy

NCT07489066Phase 2RecruitingPrimary

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

NCT03331601Phase 2TerminatedPrimary

Evaluation of 68-GaNOTA-Anti-HER2 VHH1 Uptake in Brain Metastasis of Cancer Patients

NCT04897321Phase 1Recruiting

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

NCT07587814Not ApplicableNot Yet RecruitingPrimary

Impact of Body Composition on Dosimetry of 177Lu-PSMA Radioligand Therapy

NCT06445114Phase 2Recruiting

Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer

NCT03857620Not ApplicableActive Not Recruiting

Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer

NCT07365124Not Yet RecruitingPrimary

MRinRT: Swansea University and SWWCC Collaboration Study.

NCT06456411Not ApplicableTerminated

Functional Near-Infrared Spectroscopy and Virtual Reality Relaxation Programs for Pain Management in Patients With Cancer

NCT04483778Phase 1Active Not Recruiting

B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

NCT03778229Phase 2Active Not RecruitingPrimary

Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib

NCT05559879Phase 1Recruiting

Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma

NCT03091192Phase 3Active Not RecruitingPrimary

Savolitinib vs. Sunitinib in MET-driven PRCC.

NCT05461430Completed

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

NCT07257094RecruitingPrimary

Nasal Reconstruction FACE-Q : French Validation of the Nasal Reconstruction FACE-Q Questionnaire for Reconstruction/Rehabilitation Following Nasal Skin Cancer

NCT06630273Not Yet RecruitingPrimary

Canadian Initiative to Measure, Predict and Assess Cancer Treatment Outcomes in Patients Treated With Immuno-Oncotherapeutics

NCT05065736Early Phase 1Recruiting

Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer

NCT06128343Recruiting

Anatomical-Clinical Base of Adenocarcinoma Pancreatic

NCT07470827Active Not Recruiting

Evaluation of 'WAYMED Endo CL CS' for Automated Detection and Diagnosis of Colorectal Adenoma and Non-Adenoma Lesions

Scroll to load more

Research Network

Activity Timeline